These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 34489699)

  • 1. Acute Pharmacological Effects and Oral Fluid Concentrations of the Synthetic Cannabinoids JWH-122 and JWH-210 in Humans After Self-Administration: An Observational Study.
    Martínez L; La Maida N; Papaseit E; Pérez-Mañá C; Poyatos L; Pellegrini M; Pichini S; Ventura M; Galindo L; Busardò FP; Farré M
    Front Pharmacol; 2021; 12():705643. PubMed ID: 34489699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute Pharmacological Effects and Oral Fluid Biomarkers of the Synthetic Cannabinoid UR-144 and THC in Recreational Users.
    Maida N; Papaseit E; Martínez L; Pérez-Mañá C; Poyatos L; Pellegrini M; Pichini S; Pacifici R; Ventura M; Galindo L; Busardò FP; Farré M
    Biology (Basel); 2021 Mar; 10(4):. PubMed ID: 33805054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intoxication by a synthetic cannabinoid (JWH-018) causes cognitive and psychomotor impairment in recreational cannabis users.
    Theunissen EL; Reckweg JT; Hutten NRPW; Kuypers KPC; Toennes SW; Neukamm MA; Halter S; Ramaekers JG
    Pharmacol Biochem Behav; 2021 Mar; 202():173118. PubMed ID: 33497715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute Pharmacological Effects of Oral and Intranasal Mephedrone: An Observational Study in Humans.
    Papaseit E; Olesti E; Pérez-Mañá C; Torrens M; Fonseca F; Grifell M; Ventura M; de la Torre R; Farré M
    Pharmaceuticals (Basel); 2021 Jan; 14(2):. PubMed ID: 33525579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Comparison of Acute Pharmacological Effects of Methylone and MDMA Administration in Humans and Oral Fluid Concentrations as Biomarkers of Exposure.
    Poyatos L; Papaseit E; Olesti E; Pérez-Mañá C; Ventura M; Carbón X; Grifell M; Fonseca F; Torrens M; de la Torre R; Farré M
    Biology (Basel); 2021 Aug; 10(8):. PubMed ID: 34440023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute Effects of 2C-E in Humans: An Observational Study.
    Papaseit E; Olesti E; Pérez-Mañá C; Torrens M; Grifell M; Ventura M; Pozo OJ; de Sousa Fernandes Perna EB; Ramaekers JG; de la Torre R; Farré M
    Front Pharmacol; 2020; 11():233. PubMed ID: 32256350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychotomimetic symptoms after a moderate dose of a synthetic cannabinoid (JWH-018): implications for psychosis.
    Theunissen EL; Reckweg JT; Hutten NRPW; Kuypers KPC; Toennes SW; Neukamm MA; Halter S; Ramaekers JG
    Psychopharmacology (Berl); 2022 May; 239(5):1251-1261. PubMed ID: 33501595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute Pharmacological Effects of 2C-B in Humans: An Observational Study.
    Papaseit E; Farré M; Pérez-Mañá C; Torrens M; Ventura M; Pujadas M; de la Torre R; González D
    Front Pharmacol; 2018; 9():206. PubMed ID: 29593537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurocognition and subjective experience following acute doses of the synthetic cannabinoid JWH-018: a phase 1, placebo-controlled, pilot study.
    Theunissen EL; Hutten NRPW; Mason NL; Toennes SW; Kuypers KPC; de Sousa Fernandes Perna EB; Ramaekers JG
    Br J Pharmacol; 2018 Jan; 175(1):18-28. PubMed ID: 29164599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methodology for controlled administration of smoked synthetic cannabinoids JWH-018 and JWH-073.
    Cooper ZD; Poklis JL; Liu F
    Neuropharmacology; 2018 May; 134(Pt A):92-100. PubMed ID: 29146503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the Neurotoxic and Seizure-Inducing Effects of Synthetic and Endogenous Cannabinoids with Δ
    Breivogel CS; Wells JR; Jonas A; Mistry AH; Gravley ML; Patel RM; Whithorn BE; Brenseke BM
    Cannabis Cannabinoid Res; 2020 Mar; 5(1):32-41. PubMed ID: 32322674
    [No Abstract]   [Full Text] [Related]  

  • 12. Determination of the Synthetic Cannabinoids JWH-122, JWH-210, UR-144 in Oral Fluid of Consumers by GC-MS and Quantification of Parent Compounds and Metabolites by UHPLC-MS/MS.
    La Maida N; Pellegrini M; Papaseit E; Pérez-Mañá C; Poyatos L; Ventura M; Galindo L; Busardò FP; Pichini S; Farré M; Marchei E
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33321929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concentrations of APINACA, 5F-APINACA, UR-144 and its degradant product in blood samples from six impaired drivers compared to previous reported concentrations of other synthetic cannabinoids.
    Karinen R; Tuv SS; Øiestad EL; Vindenes V
    Forensic Sci Int; 2015 Jan; 246():98-103. PubMed ID: 25485949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic properties of the synthetic cannabinoid JWH-018 in oral fluid after inhalation.
    Toennes SW; Geraths A; Pogoda W; Paulke A; Wunder C; Theunissen EL; Ramaekers JG
    Drug Test Anal; 2018 Apr; 10(4):644-650. PubMed ID: 28967189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurocognition and Subjective Experience Following Acute Doses of the Synthetic Cannabinoid JWH-018: Responders Versus Nonresponders.
    Theunissen EL; Hutten NRPW; Mason NL; Toennes SW; Kuypers KPC; Ramaekers JG
    Cannabis Cannabinoid Res; 2019; 4(1):51-61. PubMed ID: 31363493
    [No Abstract]   [Full Text] [Related]  

  • 16. Novel halogenated derivates of JWH-018: Behavioral and binding studies in mice.
    Vigolo A; Ossato A; Trapella C; Vincenzi F; Rimondo C; Seri C; Varani K; Serpelloni G; Marti M
    Neuropharmacology; 2015 Aug; 95():68-82. PubMed ID: 25769232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for enduring cardiac and multiorgan toxicity after repeated exposure to the synthetic cannabinoid JWH-018 in male rats.
    Pintori N; Serra MP; Carai A; Lobina C; Isola R; Noli R; Piras G; Spano E; Baumann MH; Quartu M; De Luca MA
    Toxicology; 2024 Sep; 507():153878. PubMed ID: 38972446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthetic cannabinoid JWH-018 and its halogenated derivatives JWH-018-Cl and JWH-018-Br impair Novel Object Recognition in mice: Behavioral, electrophysiological and neurochemical evidence.
    Barbieri M; Ossato A; Canazza I; Trapella C; Borelli AC; Beggiato S; Rimondo C; Serpelloni G; Ferraro L; Marti M
    Neuropharmacology; 2016 Oct; 109():254-269. PubMed ID: 27346209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of an activity-based receptor bioassay to investigate the in vitro activity of selected indole- and indazole-3-carboxamide-based synthetic cannabinoids at CB1 and CB2 receptors.
    Noble C; Cannaert A; Linnet K; Stove CP
    Drug Test Anal; 2019 Mar; 11(3):501-511. PubMed ID: 30280499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of the Abuse Liability of Synthetic Cannabinoid Agonists JWH-030, JWH-175, and JWH-176.
    Tampus R; Yoon SS; de la Peña JB; Botanas CJ; Kim HJ; Seo JW; Jeong EJ; Jang CG; Cheong JH
    Biomol Ther (Seoul); 2015 Nov; 23(6):590-6. PubMed ID: 26535085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.